Correlation Between Regenxbio and Biohaven Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on Regenxbio and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Biohaven Pharmaceutical.

Diversification Opportunities for Regenxbio and Biohaven Pharmaceutical

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Regenxbio and Biohaven is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of Regenxbio i.e., Regenxbio and Biohaven Pharmaceutical go up and down completely randomly.

Pair Corralation between Regenxbio and Biohaven Pharmaceutical

Given the investment horizon of 90 days Regenxbio is expected to under-perform the Biohaven Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Regenxbio is 1.08 times less risky than Biohaven Pharmaceutical. The stock trades about -0.02 of its potential returns per unit of risk. The Biohaven Pharmaceutical Holding is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1,543  in Biohaven Pharmaceutical Holding on August 30, 2024 and sell it today you would earn a total of  3,095  from holding Biohaven Pharmaceutical Holding or generate 200.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Regenxbio  vs.  Biohaven Pharmaceutical Holdin

 Performance 
       Timeline  
Regenxbio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regenxbio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Biohaven Pharmaceutical 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Biohaven Pharmaceutical Holding are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Biohaven Pharmaceutical displayed solid returns over the last few months and may actually be approaching a breakup point.

Regenxbio and Biohaven Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regenxbio and Biohaven Pharmaceutical

The main advantage of trading using opposite Regenxbio and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.
The idea behind Regenxbio and Biohaven Pharmaceutical Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets